FlowFATE: New project uses AI to improve leukemia treatment monitoring
FlowFATE: New project uses AI to improve leukemia treatment monitoring The Vienna Business Agency has awarded a research grant to Margarita Maurer-Granofszky, Staff Scientist in Michael Dworzak’s lab, to develop improved flow cytometry-based diagnostics in leukemia using AI. In Simple Terms– Detecting even very small numbers of leukemic cells in a patient’s blood is essential
FlowFATE: New project uses AI to improve leukemia treatment monitoring Read More »















